Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.19 per share a year ago.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Brian Norris - Corporate Participant George Chris Kutsor - Chief Financial Officer John Kedzierski - President, CEO & Executive Director Conference Call Participants Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division Gareth Daniel Gacetta - Cantor Fitzgerald & Co., Research Division Jeremy Scott Hamblin - Craig-Hallum Capital Group LLC, Research Division Shaul Eyal - TD Cowen, Research Division Operator Good afternoon, and welcome to the Evolv Technologies Second Quarter Earnings Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.02 per share a year ago.
Evolv Technologies appears to be in a good way with new management, outperforming peers and transitioning to a small-cap with 85% gains since our last review. The company now faces a key test in the shape of Q2 earnings due to be released on the 14th of August. We touch upon some of the key narratives that could dominate the earnings event, with revenue growth expected to slow and gross margin pressure likely to be felt.
Evolv Technologies (EVLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
VRNA and EVLV made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 7, 2025.
Evolv Technologies (EVLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Evolv Technologies is a Buy for me, driven by strong SaaS adoption, expanding recurring revenue, and clear market relevance in education and healthcare. Financials show robust ARR growth, improving margins, and disciplined cost control, with a strong balance sheet and no long-term debt. Key growth drivers include rising demand in schools, hospitals, and public venues, plus new products and a Certified Pre-Owned program to broaden market reach.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV ) Q1 2025 Earnings Conference Call May 20, 2025 4:30 PM ET Company Participants Brian Norris - SVP of Finance and IR John Kedzierski - President and CEO Chris Kutsor - CFO Conference Call Participants Jeremy Hamblin - Craig Hallum Michael Latimore - Northland Capital Markets Eric Martinuzzi - Lake Street Capital Markets Brett Knoblauch - Cantor Fitzgerald Operator Good afternoon and welcome to the Evolv Technology First Quarter Earnings Result Conference Call. All participants are in a listen-only mode.
Evolv: Huge Upside Potential From A Life-Saving Technology
NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Evolv Technologies shares are riding on strategic partnerships and an expanding footprint. Yet, macroeconomic challenges are concerning.